Condensia participes in the Horizon 2020 NextGen Microfluidics Project carrying out exensive research into the next generation of lab-on-a-chip systems. So called mini-labs using foil-based microfluidics for rapid diagnostics kits can then be mass-produced in Europe, with possible application in COVID-19 detection.
The Project combines the competences of 21 companies and research organizations along the entire value chain, with a budget of 15 million Euros for the next 4 years.
For further information, please visit www.nextgenmicrofluidics.eu
